Oligomycin reveals the portion of oxygen consumption linked to ATP production by preventing proton flow through the ATP synthase channel. As a result, the difference between respiration before and after oligomycin treatment estimates ATP-linked respiration in the tested cells. In immune or infected-cell models, this helps determine whether metabolic changes affect energy generation.
Rotenone acts at Complex I, whereas antimycin acts at Complex III, so the two inhibitors interrupt electron transfer at different locations. Their distinct positions help researchers determine how much measured oxygen consumption depends on electron transport through these complexes. In infection or immune activation models, contrasting responses can indicate which part of respiratory metabolism is most affected.
Sequential treatment creates a functional partition of oxygen consumption rather than a single endpoint. Oligomycin first separates ATP-linked respiration from other oxygen use, while later respiratory inhibitors disrupt electron transport at defined complexes. The resulting changes allow investigators to distinguish mitochondrial contributions, residual non-mitochondrial consumption, and electron transport capacity in the same experimental model.
Changes in oxygen consumption after each inhibitor provide a metabolic signature of the cells’ condition. Immune activation, inflammation, or pathogen challenge may alter ATP-linked respiration, electron transport, or non-mitochondrial oxygen use. Examining the pattern across inhibitor steps is therefore more informative than treating a single oxygen-consumption value as a complete description of mitochondrial function.
A sequential assay follows oxygen consumption across defined treatment stages: measure the cellular respiratory signal, add oligomycin, and then apply rotenone and antimycin to interrupt electron transport at their respective sites. Comparing the readings at each stage separates ATP-linked respiration from other components. The procedure is applicable to immune-cell and infected-cell models.
Interpretation depends on the change produced by each compound, not simply on the final reading. A decrease after oligomycin reflects the ATP-linked component, whereas responses to rotenone and antimycin report the contribution of electron transport at Complex I and Complex III. Remaining oxygen consumption can be distinguished as the non-mitochondrial component described by the assay.
In immunology and infection research, this inhibitor sequence can compare mitochondrial metabolism across activated, inflamed, or pathogen-challenged cellular models. The measurements help connect altered respiration with immune-cell performance and with metabolic changes associated with disease progression. Because the same framework examines several respiratory components, it supports mechanistic comparisons between cellular conditions.